Dr. Tommaso Fasano
Santa Maria Nuova Hospital
Reggio Emilia, Italy
Videos: Evaluating High-Sensitivity Troponin I Assays
Three videos summarize the excellent performance of the Atellica® IM High-Sensitivity Troponin I assay
Dr. Ankur Srivastava
Consultant Gastroenterologist and Hepatologist
Southmead Hospital, North Bristol Trust
Non-invasive tests can help reduce unnecessary referrals in patients with NAFLD
Dr. Arun J. Sanyal
Professor, Gastroenterology, Hepatology and Nutrition
Virginia Commonwealth University
The need for non-invasive testing in liver fibrosis assessment
Dr. Zobair M. Younossi
Professor & Chairman of Medicine,
Inova Fairfax Hospital, Virginia
Prevalence of NAFLD in patients with both type 2 diabetes and obesity is over 75%
Dr. Paul Collinson
St. George's University of London
Professor of Cardiovascular Biomarkers
Cardiac troponin is a marker of cardiac injury, enabling clinicians to aid in the diagnosis of myocardial infarction.
Dr. Rick Body
University of Manchester and Manchester University NHS Foundation Trust
Reduce ER Wait Times with High-Sensitivity Troponin I Diagnostic Algorithm
Dr. Fred Apple
Medical Director of Clinical Laboratories
Hennepin County Medical Center
The role of high-sensitivity troponin I in the earlier diagnosis of AMI.
Alan Wu, Ph.D.
Professor of Laboratory Medicine, University of California San Francisco
How do we do a better job of triaging emergency room patients to receive the proper level of care?
Dr. Pete Kavsak
Clinical Chemist, Juravinski Hospital
Collaboration with colleagues is crucial when transitioning to a high-sensitivity troponin I assay into your lab
Dr. Frank Peacock
Professor, Department of Emergency Medicine
Associate Chair and Research Director, Baylor College of Medicine
Cardiac biomarkers are providing earlier detection in the emergency room.